Cornercap Investment Counsel’s Meridian Bioscience Inc VIVO Stock Holding History

Cornercap Investment Counsel’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-19,062	Closed	-$336K	–	487
2019 Q1	$336K	Sell	19,062 -6,259	-25%	-$104K	0.05%	370
2018 Q4	$440K	Hold	25,321	–	–	0.07%	358
2018 Q3	$377K	Sell	25,321 -2,832	-10%	-$43.9K	0.05%	375
2018 Q2	$448K	Sell	28,153 -28,229	-50%	-$421K	0.06%	365
2018 Q1	$801K	Sell	56,382 -19,879	-26%	-$294K	0.11%	213
2017 Q4	$1.07M	Sell	76,261 -40	-0.1%	-$586	0.15%	169
2017 Q3	$1.09M	Buy	+76,301	New	+$1.09M	0.15%	168

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cornercap Investment Counsel's VIVO Position: Q2 2019 in Review

Cornercap Investment Counsel sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 19,062 shares — an estimated $336K sold.

Cornercap Investment Counsel first reported a position in VIVO in Q3 2017 and held it in 7 quarters. The position peaked at $1.09M in Q3 2017. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

Cornercap Investment Counsel reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
Cornercap Investment Counsel sold 19,062 Meridian Bioscience Inc shares in Q2 2019, an estimated $336K.
Cornercap Investment Counsel first reported a position in Meridian Bioscience Inc in Q3 2017 and held it in 7 quarters.
Cornercap Investment Counsel's Meridian Bioscience Inc position peaked at $1.09M in Q3 2017.
173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Cornercap Investment Counsel's 13F filing for Q2 2019, filed 14 Aug 2019.